Novel artificial intelligence platform for drug development and personalized medicine
Our current applications
Our Services
HEALTH CARE ONCOLOGY WORKFLOW
HEALTH CARE ONCOLOGY WORKFLOW
- FDA Approved Drugs
- Medical indications
- Pharmacology toxicities
- Drugs interactions
- Ongoing clinical studies
- European and American guidelines
- Molecular Biomarkers for personalized medicine
- Real World Data
- Best workflow to reduce medical effort
PRECISION MEDICINE SOLUTIONS
PRECISION MEDICINE SOLUTIONS
- Genomic Molecular Alterations
- Evaluation of oncogenic molecular panels
- Druggable vulnerabilities
- Targered agents
- Therapeutic opportunities
- Drug combinations
- Ongoing clinical studies
- Identification of best treatment based on propietary algorithms
BIOMARKER AND DRUG DEVELOPER
BIOMARKER AND DRUG DEVELOPER
- Genomic molecular alterations
- Potential target inhibition
- Druggable vulnerabilities
- Current clinical development
- Competitive landscape
- Target population and indication
- Evaluation of attrition rate
- Pharma intelligent
- Identification of best clinical development
What we do
This platform uses data from different sources including molecular alterations, scientific results, clinical trials, combinations of compounds, described efficacy, competitive landscape, in addition to side effects or potential interactions, to provide the user with all relevant data in a customized manner, without the necessity to obtain this information through complex consulting dossiers.
In addition, we are developing algorithms that can help to predict the success of a new pharmacological compound through the identification of unmet necessities, empty areas, potential side effects or combinations that would not reach the clinical setting, as well as crowded sectors or areas for business development.

Request an online test
We would be happy to show you our platform.
SOSA – BEAZ program
This year 2021 starts very strong for Cancerappy. "Our project has been selected for the SOSA Tel Aviv-Beaz Bizkaia acceleration program." Hopefully, and as long as the covid19 let us, in May we will be in Tel Aviv developing our skills and networking with local...
Cancerappy awarded the prize for entrepreneurial initiative
Award #Premiosanjuan20 for Cancerappy… and its investors. In this month the emblematic San Juan 2020 Awards of the Albacete Business Association took place in which, this year, Luis Martín, our CEO and Co-founder of Cancerappy, has been awarded the prize for...
Cancerappy has obtained Neotec2020
We cannot be more proud and happy with our team since Cancerappy has obtained the positive resolution of the Neotec 2020 program in this especially competitive year.